Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB-ALIP vs NITROGLYCERIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB-ALIP vs NITROGLYCERIN: Safety Overview

Metric NIRSEVIMAB-ALIP NITROGLYCERIN
Total FAERS Reports 783 7,431
Deaths Reported 32 962
Death Rate 4.1% 12.9%
Hospitalizations 281 3,185
Average Patient Age 3.3 yrs 69.7 yrs
% Female Patients 46.3% 63.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Boiron
Route N/A ORAL
Marketing Status Prescription Discontinued